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“Art and Biochemistry Applied to Snakebite Treatment: Medical Illustration and
Biochemical Investigations of the bacterial production of metalloproteinase inhibitors from
the North American opossum D. virginiana.”

Allison Soffa
Grand Valley State University

Abstract
Various opossum species are resistant to snake venoms due to the presence of
antihemorrhagic and antimyotoxic acidic serum glycoproteins that inhibit several toxic venom
components. Snake-bite envenomation is a global health concern, and a better understanding of
these proteins may provide useful insight to determine their mechanism of action and for the
development of therapeutics Two identical antihemorrhagic proteins, termed oprin or DM43,
isolated from either the North American opossum (D. virginiana) or the South American bigeared opossum (D. aurita), inhibit specific snake venom metalloproteinases (SVMPs). The aim
of this work is to produce a recombinant snake venom metalloproteinase inhibitor (SVMPI)
similar to the above opossum proteins. Eight constructs including the genes for the production of
the proteins DM43 and maltose binding protein (MBP) were created in Escherichia coli vectors.
The resulting construct was produced with a 6-Histidine and maltose binding protein (MBP)
affinity tag on either the C-terminus or N-terminus of the protein, respectively. Four of the eight
constructs were then used in the optimization of the enzymatic cleavage reaction between
tobacco etch virus (TEV) and the fusion protein MBP-DM43 created by the vector. This new
construct replaces a Factor Xa cleavage site with a TEV cleavage site. The cleavage reaction for
the first construct (Assembly #1) was monitored and the use of the TEV cleavage site appears to
be an efficient way to cleave the DM43 from the MBP in the fusion protein in that construct. A
series of illustrations were created to accompany the scientific history and lab processes
regarding this research.

Materials and Methods

Reagents and Materials
LB media, tryptone, yeast extract, agar, agarose, ethidium bromide, sodium chloride,
calcium chloride, sodium phosphate, Tris-HCl, Tris base, ampicillin, kanamycin, EDTA
(ethylenediamine tetraacetic acid), ethanol, methanol, DMSO (dimethylsulfoxide), DTT
(dithiothreitol), and IPTG (Isopropyl

-D-1-thiogalactopyranoside) were obtained from Sigma

(St. Louis, MO). The pMAL-c6t plasmid, NEBuilder HiFi DNA assembly 2X master mix, Q5
Hot Start High-Fidelity 2X Master Mix, OneTaq 2X Master Mix with standard buffer, NEB 5- a
competent E. coli (High Efficiency), NEBExpress competent E. coli (High Efficiency), Monarch
Plasmid Miniprep Kit, Monarch DNA Gel Extraction Kit, CutSmart buffer 10X, restriction
enzymes (XmnI, DpnI, BamHI-HF, NcoI-HF, XbaI), Purple 6X-load dye, and 1KB Molecular
Weight DNA ladder were obtained from New England Biolabs (NEB) (Ipswich, MA). Wizard
Plasmid Miniprep Kit was obtained from Promega (Madison, WI). BL21(DE3) competent E.
coli cells were obtained from EMDMillipore (Burlington, MA). HiPur Ni-NTA Resin and
HALT protease inhibitor were obtained from ThermoFisher Scientific (Waltham, MA). All
disposable plasticware and both clear and black 96-well microplates were from VWR
International (Radnor, PA). Mini-PROTEAN Tetra vertical electrophoresis cell, 4–20% MiniPROTEAN TGX SDS-PAGE pre-cast protein gels, microcentrifuge tube roller, 10X TrisGlycine SDS-PAGE buffer, 2X Laemmli sample buffer, protein assay dye concentrate (Bradford
reagent), and Precision Plus Protein Kaleidoscope pre-stained protein molecular weight standard
were from Bio-Rad (Hercules, CA). 2-aminobenzoyl-Ala-Gly-Leu-Ala-4-nitrobenzylamide
(Abz-NGLA-Nbz) was obtained from Peptides International (Louisville, KY). Freeze-dried

Crotalus atrox (C. atrox) venom was obtained from the National Natural Toxins Research Center
at Texas A&M Kingsville. Synthetic desalted PCR primers (all primer sequences listed in the
supplemental section) were obtained from Integrated DNA Technologies (Skokie, IL). A
synthetic DNA encoding for the oprin DM43-like gene-product derived from a D. virginiana
cDNA sequence (GenBank Accession number AY131001.1) inserted into the pUC19 vector was
obtained from GeneScript Corporation (Piscataway, NJ). This pUC19-oprin construct contained
HindIII restriction sites immediately upstream and downstream of the oprin coding sequence
(876 bp) as well as an inserted TGA stop codon at the 3’-end of the sequence (see supplemental
information for complete pUC19-oprin DM43-like vector sequence).

General Methods
PCR was performed using specific primers (sequences listed in the supplemental section
of this paper) and an Applied Biosystems Veriti thermocycler Model 9902 (ThermoFisher
Scientific Waltham, MA), DNA visualization was performed using 1.0% agarose gels stained
with EtBr and DNA concentration was measured with a microvolume UV spectrophotometer,
namely the NanoDrop2000 (ThermoFisher Scientific Waltham, MA). LB/Amp and LB/Kan
liquid media and plates had final ampicillin and kanamycin concentrations of 100 mg/L and 30
mg/L, respectively. Proteins were concentrated using Amicon Ultra (10K MWCO) centrifugal
concentrators. Protein concentrations were measured using either the Bio-Rad Bradford
(Bradford, 1976) protein assay (Hercules, CA) or proteins were diluted in 8M guanidine
hydrochloride followed by micro-cuvette UV-vis measurements using an Agilent Cary 60 UVVis spectrophotometer and calculated extinction coefficients (ExPASy ProtParam
tool).(Gasteiger et al., 2005) Protein electrophoresis was performed with either a Bio-Rad

(Hercules, CA) Mini-Protean 3 Cell or a Mini Trans-Blot Electrophoretic Transfer Cell. SDSPAGE gels were stained with Coomassie blue stain. Micro-plate assays (for protein
concentration and kinetic fluorescent assays) were performed using a BioTek Synergy H1
Hybrid Reader (Winooski, VT). Centrifugation was accomplished using either a fixed angle
VWR BenchMate micro-centrifuge, an Eppendorf 5417C microcentrifuge, a ThermoScientific
Sorvall Lynx 400 fixed angle centrifuge, or a ThermoScientific Sorvall Legend X1 swinging
bucket centrifuge. Sanger di-deoxy sequencing was performed at either University of Michigan
Sequencing Core (Ann Arbor, MI) or Macrogen (Rockville, MD). IC50 values were calculated
using GraphPad Prism version 8.4.2 for Windows, GraphPad Software (San Diego, CA)

Gibson Assembly of TEV Constructs (Summer 2021)
PRIMERS listed BELOW
(Assembly 1) Gibson Assembly of pMAL-c6t-TEV-DM43 expression vector
Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using Q5 Hot
Start High-Fidelity Polymerase 2X master mix with primers C and D (primer sequences
provided in supplemental). The 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix,
1.25µL of 10µM primer C, 1.25 µL of 10 µM primer D, 1µL of pMAL-c6t template DNA (~1
pg), and 9 µL ultrapure H2O. PCR thermocycler reaction conditions for the construction of the
pMAL-c6t assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC,
4.0 min 72 oC (35 cycles); Stage 3: 10.0 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pMAL-c6t regions on both ends of the oprin(DM43) coding
sequence, the appropriate region of the synthetic pUC19-oprin(DM43) plasmid (Genescript) was

amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix and primers E and F.
The 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix, 1.25 µL of 10 µM primer E,
1.25 µL of 10 µM primer F, 1µL (~2 pg) of synthetic pUC19-oprin(DM43) template DNA, and
9 µL ultrapure H2O. PCR thermocycler reaction conditions for the construction of the oprin
assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 30 sec 72 oC
(35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified by
1% agarose gel (stained with EtBr) (see supplemental), bands were excised, DNA was isolated
using a Monarch DNA Gel Extraction Kit, and DNA concentration was determined using a
micro-volume spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction

PCR reaction
Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
o

C in a reaction containing 8 µL (134 ng) of linearized pMAL-c6t, 1µL of 10X CutSmart buffer,

and 1 µL (20 units) of DpnI, followed by 20 min heat inactivation at 80 oC. Gibson Assembly

conditions were as follows: 0.06 pmol of the pMAL-c6t linearized fragment (vector) and 0.12
pmol of the oprin(DM43) assembly fragment (insert) (~1:2 vector/insert ratio) were combined in
a 20 µL assembly reaction with 10 µL of NEBuilder HiFi DNA 2X assembly master mix and
held at 50 oC for 30 min. NEB 5-a competent E. coli cells (NEB) were then transformed with 2
µL of this assembly reaction following the manufacturer’s 42 oC heat-shock protocol, incubated
in SOC media at 37 oC for 60 min, and 100 µL was then spread on LB/Amp agar plates, and
incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Six colonies from Assembly 1 were randomly screened by colony PCR in separate 25 µL
reactions using OneTaq Quick-Load 2X Master Mix with standard buffer and DM43 specific
primers A and B (876 BP amplicon). PCR reactions contained: 12.5 µL OneTaq, 1.25 µL of 10
µM primer A, 1.25 µL of 10 µM of primer B, and 10 µL ultrapure H2O, and individual colonies
were picked with a sterile micro-pipette tip as the DNA source (note: these same tips were used
to inoculate separate 10 mL LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm.
PCR thermocycler conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC,
30 sec 56 oC, 60 sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR
results were visualized by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a
negative control reaction with no DNA and a negative primer control with only one primer were
also run – Lanes 7 and 8 respectively)

Lane
1- 1KB DNA ladder
2- Blank
3- Colony 1A
4- Colony 1B
5- Colony 1C
6- Colony 1D
7- Colony 1E
8- Colony 1F
9- Negative control
10- Primer negative control

DNA isolation and sequencing
Plasmid DNA from the three Assembly 1 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit (NEB or
Promega), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these
purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San
Francisco, CA) using primers AA and BB. Reads were trimmed and aligned (data not shown)

using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

Transformation of Assembly 1
The pMAL-c6t-oprin construct from Assembly 1 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for the
expression of MPB-fusion proteins because it is ideal for Ptac expression vectors such as pMALc6t and is deficient in proteases Lon and OmpT. The transformed cells (100 µL) were then
spread onto LB/Amp plates and grown overnight at 37 oC.

Expression and purification of Assembly 1 (6-His-MBP-TEV-DM43 fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM43
constructs from Assembly 1 were screened for IPTG-induced protein production by inoculating
four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG, incubated at 37 oC
with overnight shaking at 250 rpm, and protein production was assessed via SDS-PAGE
inspection. Once screened, the transformation colony showing the most IPTG-induced protein
production was subjected to large-scale expression of the N-terminal MBP-oprin protein. This
was accomplished by inoculating 1 L of liquid LB/Amp/Glu (containing 1mM glucose) media
with a 10 mL starter culture of NEBExpress E. coli cells containing the previously screened
Assembly 2 transformed colony. (Note: The addition of glucose is recommended as it inhibits
the production of amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until the
cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG (final

concentration of 1 mM) was added and the cells were incubated at 30 oC for an additional six
hours. (Note: we found that if cultures were grown at 37 oC or for extended time periods,
significant inclusion body formation was observed, data not shown). The cells were then
harvested at 4,000 G at 4 oC, the supernatant was decanted, and the cell pellets were frozen at -20
o

C overnight. The cell pellets were re-suspended in a total of 60 mL of column buffer (20 mM

Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme
and 100

L HALT protease inhibitor (Sigma). (Note: The addition of lysozyme and the protease

inhibitor cocktail increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated with ten
30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4 oC.

Affinity Purification with Ni-column
The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM imidazole),
the entire cell free lysate supernatant added to the resin and gently shaken at 4 oC for 1 hr. This
mixture was poured into a glass column and washed using 100 mL of wash buffer (25 mM TrisHCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate of 4.0 mL/min. The target protein
was eluted in 2.0 mL fractions using elution buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 0.5
M imidazole) with a flow rate of 4.0 mL/min. Eluted fractions were examined for quantity and
purity using the Bradford protein assay and SDS-PAGE, the fractions containing purified MBPTEV-DM43 pooled.

Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the column
buffer for equilibration and rinsing of the amylose column significantly reduced non-specific
binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse the column with 100
mL of column buffer with 1M NaCl added, and the MBP-TEV-DM43 fusion protein was eluted
into 3 mL fractions with column buffer containing 10 mM maltose but lacking the added 1M
NaCl. Eluted fractions were examined for quantity and purity using the Bradford protein assay
and SDS-PAGE, the fractions containing the purified MBP-TEV-DM43 fusion protein were
pooled and concentrated to a final concentration of 5.0 mg/ml (~67 nM, based on a calculated
molecular weight of 75,001 g/mol and a calculated extinction coefficient of 122,245 M-1cm-1)
(values obtained from the ExPASy ProtParam tool).(Gasteiger et al., 2005)

(Assembly 2) Gibson Assembly of pMAL-c6t-TEV-DM43 (Ala) expression vector
Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using Q5 Hot
Start High-Fidelity Polymerase 2X master mix with primers C and D (primer sequences
provided in supplemental). The 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix,
1.25 µL of 10 µM primer C, 1.25 µL of 10 µM primer D, 1µL of pMAL-c6t template DNA (~1
pg), and 9 µL ultrapure H2O. PCR thermocycler reaction conditions for the construction of the
pMAL-c6t assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC,
4.0 min 72 oC (35 cycles); Stage 3: 10.0 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pMAL-c6t regions on both ends of the oprin(DM43) (L1A
mutant) coding sequence, the appropriate region of the synthetic pUC19-oprin(DM43) plasmid
(Genescript) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix and
primers G and H. The 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix, 1.25 µL of
10 µM primer G, 1.25 µL of 10 µM primer H, 1 µL (~2 pg) of synthetic pUC19-oprin(DM43)
template DNA, and 9 µL ultrapure H2O. PCR thermocycler reaction conditions for the
construction of the oprin assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC,
30 sec 65 oC, 30 sec 72 oC (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment
lengths were verified by 1.0% agarose gel (stained with EtBr) (see supplemental), bands were
excised, DNA was isolated using a Monarch DNA Gel Extraction Kit, and DNA concentration
was determined using a micro-volume spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43
(insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43
(insert 1) ½ of PCR reaction
4 oprin insert (876 BP) –
previously synthesized
5 pET-6His-MBP-10AsnTEV-DM43 (insert 5) ½ of
PCR reaction
6 pET-6His-MBP-10AsnTEV-DM43 (insert 5) ½ of

Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
o

C in a reaction containing 8

L (134 ng) of linearized pMAL-c6t, 1µL of 10X CutSmart buffer,

and 1µL (20 units) of DpnI, followed by 20 min heat inactivation at 80 oC. Gibson Assembly
conditions were as follows: 0.06 pmol of the pMAL-c6t linearized fragment (vector) and 0.12
pmol of the oprin(DM43) (L1A mutant) assembly fragment (insert) (~1:2 vector/insert ratio)

were combined in a 20 µL assembly reaction with 10 µL of NEBuilder HiFi DNA 2X assembly
master mix and held at 50 oC for 30 min. NEB 5-a competent E. coli cells (NEB) were then
transformed with 2 µL of this assembly reaction following the manufacturer’s 42 oC heat-shock
protocol, incubated in SOC media at 37 oC for 60 min, and 100 µL was then spread on LB/Amp
agar plates, and incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 2 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM43 specific primers A and B
(876 BP amplicon). Six colonies from the Gibson Assembly were randomly screened in separate
25 µL PCR reactions containing: 12.5 µL OneTaq, 1.25 µL of 10 µM primer A, 1.25 µL of 10
µM of primer B, and 10 µL ultrapure H2O, and individual colonies were picked with a sterile
micro-pipette tip as the DNA source (note: these same tips were used to inoculate separate 10
mL LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler
conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 56 oC, 60
sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized
by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7 and 8
respectively)

Lane
1-

1KB DNA ladder

2-

Blank

3-

Colony 2A

4-

Colony 2B

5-

Colony 2C

6-

Colony 2D

7-

Colony 2E

8-

Colony 2F

9-

Negative control

10- Primer negative control

DNA isolation and sequencing
Plasmid DNA from the three Assembly 2 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit (NEB or
Promega), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these
purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San
Francisco, CA) using primers AA and BB. Reads were trimmed and aligned (data not shown)

using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

Transformation of Assembly 2
The pMAL-c6t-oprin construct from Assembly 2 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for the
expression of MPB-fusion proteins because it is ideal for Ptac expression vectors such as pMALc6t and is deficient in proteases Lon and OmpT. The transformed cells (100 µL) were then
spread onto LB/Amp plates and grown overnight at 37 oC.

Expression and purification of Assembly (6-His-MBP-TEV-DM43 (L1A) fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM43
(L1A) constructs from Assembly 1 were screened for IPTG-induced protein production by
inoculating four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG, incubated
at 37 oC with overnight shaking at 250 rpm, and protein production was assessed via SDS-PAGE
inspection. Once screened, the transformation colony showing the most IPTG-induced protein
production was subjected to large-scale expression of the N-terminal MBP-oprin protein. This
was accomplished by inoculating 1 L of liquid LB/Amp/Glu (containing 1mM glucose) media
with a 10 mL starter culture of NEBExpress E. coli cells containing the previously screened
Assembly 2 transformed colony. (Note: The addition of glucose is recommended as it inhibits
the production of amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until the
cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG (final

concentration of 1 mM) was added and the cells were incubated at 30 oC for an additional six
hours. (Note: we found that if cultures were grown at 37 oC or for extended time periods,
significant inclusion body formation was observed, data not shown). The cells were then
harvested at 4,000 G at 4 oC, the supernatant was decanted, and the cell pellets were frozen at -20
o

C overnight. The cell pellets were re-suspended in a total of 60 mL of column buffer (20 mM

Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme
and 100

L HALT protease inhibitor (Sigma). (Note: The addition of lysozyme and the protease

inhibitor cocktail increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated with ten
30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4 oC.

Affinity Purification with Ni-column
The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM imidazole),
the entire cell free lysate supernatant added to the resin and gently shaken at 4 oC for 1 hr. This
mixture was poured into a glass column and washed using 100 mL of wash buffer (25 mM TrisHCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate of 4.0 mL/min. The target protein
was eluted in 2.0 mL fractions using elution buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 0.5
M imidazole) with a flow rate of 4.0 mL/min. Eluted fractions were examined for quantity and
purity using the Bradford protein assay and SDS-PAGE, the fractions containing purified MBPTEV-DM43 (L1A) pooled.

Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the column
buffer for equilibration and rinsing of the amylose column significantly reduced non-specific
binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse the column with 100
mL of column buffer with 1M NaCl added, and the MBP-TEV-DM43 (L1A) fusion protein was
eluted into 3 mL fractions with column buffer containing 10 mM maltose but lacking the added
1M NaCl. Eluted fractions were examined for quantity and purity using the Bradford protein
assay and SDS-PAGE, the fractions containing the purified MBP-TEV-DM43 (L1A) fusion
protein were pooled and concentrated to a final concentration of 5.0 mg/ml (~67 nM, based on a
calculated molecular weight of 75,001 g/mol and a calculated extinction coefficient of 122,245
M-1cm-1) (values obtained from the ExPASy ProtParam tool).(Gasteiger et al., 2005)

(Assembly 3) Gibson Assembly of pMAL-c6t-TEV-DM64 expression vector
Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using
Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers C and D (primer sequences
provided in supplemental). The 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix,
1.25 µL of 10 µM primer C, 1.25 µL of 10 µM primer D, 1 µL of pMAL-c6t template DNA (~1
pg), and 9µL ultrapure H2O. PCR thermocycler reaction conditions for the construction of the
pMAL-c6t assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC,
4.0 min 72 oC (35 cycles); Stage 3: 10.0 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pMAL-c6t regions on both ends of the DM64 coding sequence,
the appropriate region of the synthetic pUC19-DM64 plasmid (BioTwist) was amplified using
Q5 Hot Start High-Fidelity Polymerase 2X master mix and primers I and J. The 25 µL PCR
reaction contained: 12.5 µL of Q5 2X master mix, 1.25µL of 10µM primer I, 1.25 µL of 10 µM
primer J, 1 µL (~2 pg) of synthetic pUC19-DM64 template DNA, and 9µL ultrapure H2O. PCR
thermocycler reaction conditions for the construction of the DM64 assembly fragment were:
Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 66 oC, 60 sec 72 oC (35 cycles); Stage 3: 10
min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified by 1.0% agarose gel (stained
with EtBr) (see supplemental), bands were excised, DNA was isolated using a Monarch DNA
Gel Extraction Kit, and DNA concentration was determined using a micro-volume
spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of
PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of
PCR reaction

Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
o

C in a reaction containing 8 µL (134 ng) of linearized pMAL-c6t, 1 µL of 10X CutSmart buffer,

and 1µL (20 units) of DpnI, followed by 20 min heat inactivation at 80 oC. Gibson Assembly
conditions were as follows: 0.06 pmol of the pMAL-c6t linearized fragment (vector) and 0.12
pmol of the DM64 assembly fragment (insert) (~1:2 vector/insert ratio) were combined in a 20
µL assembly reaction with 10 µL of NEBuilder HiFi DNA 2X assembly master mix and held at
50 oC for 30 min. NEB 5-a competent E. coli cells (NEB) were then transformed with 2 µL of
this assembly reaction following the manufacturer’s 42 oC heat-shock protocol, incubated in
SOC media at 37 oC for 60 min, and 100 µL was then spread on LB/Amp agar plates, and
incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 3 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W and X
(1440 BP amplicon). Six colonies from the Gibson Assembly were randomly screened in
separate 25 µL PCR reactions containing: 12.5 µL OneTaq, 1.25 µL of 10 µM primer W, 1.25
µL of 10 µM of primer X, and 10 µL ultrapure H2O, and individual colonies were picked with a
sterile micro-pipette tip as the DNA source (note: these same tips were used to inoculate separate
10 mL LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler
conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60
sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized
by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7 and 8
respectively)

Lane
1- 1KB DNA ladder
2- Colony 3A
3- Colony 3B
4- Colony 3C
5- Colony 3D
6- Colony 3E
7- Colony 3F
8- Negative control
9- Primer negative control

DNA isolation and sequencing
Plasmid DNA from the three Assembly 3 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit (NEB or
Promega), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these
purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San
Francisco, CA) using primers AA and BB. Reads were trimmed and aligned (data not shown)

using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

Transformation of Assembly 3
The pMAL-c6t-oprin construct from Assembly 3 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for the
expression of MPB-fusion proteins because it is ideal for Ptac expression vectors such as pMALc6t and is deficient in proteases Lon and OmpT. The transformed cells (100

L) were then

spread onto LB/Amp plates and grown overnight at 37 oC.

Expression and purification of Assembly 3 (6-His-MBP-TEV-DM64 fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM64
constructs from Assembly 3 were screened for IPTG-induced protein production by inoculating
four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG, incubated at 37 oC
with overnight shaking at 250 rpm, and protein production was assessed via SDS-PAGE
inspection. Once screened, the transformation colony showing the most IPTG-induced protein
production was subjected to large-scale expression of the N-terminal MBP-oprin protein. This
was accomplished by inoculating 1 L of liquid LB/Amp/Glu (containing 1mM glucose) media
with a 10 mL starter culture of NEBExpress E. coli cells containing the previously screened
Assembly 2 transformed colony. (Note: The addition of glucose is recommended as it inhibits
the production of amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until the
cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG (final

concentration of 1 mM) was added and the cells were incubated at 30 oC for an additional six
hours. (Note: we found that if cultures were grown at 37 oC or for extended time periods,
significant inclusion body formation was observed, data not shown). The cells were then
harvested at 4,000 G at 4 oC, the supernatant was decanted, and the cell pellets were frozen at -20
o

C overnight. The cell pellets were re-suspended in a total of 60 mL of column buffer (20 mM

Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme
and 100

L HALT protease inhibitor (Sigma). (Note: The addition of lysozyme and the protease

inhibitor cocktail increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated with ten
30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4 oC.

Affinity Purification with Ni-column
The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM imidazole),
the entire cell free lysate supernatant added to the resin and gently shaken at 4 oC for 1 hr. This
mixture was poured into a glass column and washed using 100 mL of wash buffer (25 mM TrisHCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate of 4.0 mL/min. The target protein
was eluted in 2.0 mL fractions using elution buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 0.5
M imidazole) with a flow rate of 4.0 mL/min. Eluted fractions were examined for quantity and
purity using the Bradford protein assay and SDS-PAGE, the fractions containing purified MBPTEV-DM64 pooled.

Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the column
buffer for equilibration and rinsing of the amylose column significantly reduced non-specific
binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse the column with 100
mL of column buffer with 1M NaCl added, and the MBP-TEV-DM64 fusion protein was eluted
into 3 mL fractions with column buffer containing 10 mM maltose but lacking the added 1M
NaCl. Eluted fractions were examined for quantity and purity using the Bradford protein assay
and SDS-PAGE, the fractions containing the purified MBP-TEV-DM64 fusion protein were
pooled and concentrated to a final concentration of 5.0 mg/ml (~67 nM, based on a calculated
molecular weight of 75,001 g/mol and a calculated extinction coefficient of 122,245 M-1cm-1)
(values obtained from the ExPASy ProtParam tool).(Gasteiger et al., 2005)

(Assembly 4) Gibson Assembly of pMAL-c6t-TEV-DM64 (Ala) expression vector
Linearization of the pMAL-c6t vector (New England Biolabs) was accomplished using
Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers C and D (primer sequences
provided in supplemental). The 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix,
1.25 µL of 10µM primer C, 1.25 µL of 10 µM primer D, 1 µL of pMAL-c6t template DNA (~1
pg), and 9 µL ultrapure H2O. PCR thermocycler reaction conditions for the construction of the
pMAL-c6t assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC,
4.0 min 72 oC (35 cycles); Stage 3: 10.0 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pMAL-c6t regions on both ends of the DM64 (L1A mutant)
coding sequence, the appropriate region of the synthetic pUC19-DM64 plasmid (BioTwist) was
amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix and primers K and L.
The 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix, 1.25 µL of 10 µM primer K,
1.25 µL of 10 µM primer L, 1µL (~2 pg) of synthetic pUC19-DM64 template DNA, and 9 µL
ultrapure H2O. PCR thermocycler reaction conditions for the construction of the DM64
assembly fragment were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 67 oC, 60 sec 72 oC
(35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified by
1.0% agarose gel (stained with EtBr) (see supplemental), bands were excised, DNA was isolated
using a Monarch DNA Gel Extraction Kit, and DNA concentration was determined using a
micro-volume spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½ of PCR reaction
4 oprin insert (876 BP) – previously synthesized
5 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of
PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43 (insert 5) ½ of
PCR Reaction

Prior to Gibson Assembly, linearized pMAL-c6t was treated with DpnI for 30 min at 37
o

C in a reaction containing 8 µL (134 ng) of linearized pMAL-c6t, 1µL of 10X CutSmart buffer,

and 1µL (20 units) of DpnI, followed by 20 min heat inactivation at 80 oC. Gibson Assembly
conditions were as follows: 0.06 pmol of the pMAL-c6t linearized fragment (vector) and 0.12
pmol of the DM64 assembly fragment (insert) (~1:2 vector/insert ratio) were combined in a 20
µL assembly reaction with 10 µL of NEBuilder HiFi DNA 2X assembly master mix and held at
50 oC for 30 min. NEB 5-a competent E. coli cells (NEB) were then transformed with 2 µL of
this assembly reaction following the manufacturer’s 42 oC heat-shock protocol, incubated in

SOC media at 37 oC for 60 min, and 100 µL was then spread on LB/Amp agar plates, and
incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 4 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W and X
(1440 BP amplicon). Six colonies from the Gibson Assembly were randomly screened in
separate 25 µL PCR reactions containing: 12.5 µL OneTaq, 1.25 µL of 10 µM primer W, 1.25µL
of 10 µM of primer X, and 10 µL ultrapure H2O, and individual colonies were picked with a
sterile micro-pipette tip as the DNA source (note: these same tips were used to inoculate separate
10 mL LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler
conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60
sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized
by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7 and 8
respectively)

Lane
1- 1KB DNA ladder
2- Colony 4A
3- Colony 4B
4- Colony 4C
5- Colony 4D
6- Colony 4E
7- Colony 4F
8- Negative control

DNA isolation and sequencing
Plasmid DNA from the three Assembly 4 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using a Miniprep Kit (NEB or
Promega), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these
purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San
Francisco, CA) using primers AA and BB. Reads were trimmed and aligned (data not shown)
using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

Transformation of Assembly 4
The pMAL-c6t-oprin construct from Assembly 4 was transformed into NEBExpress E.
coli cells (NEB) following the manufacture’s protocol. This strain is recommended for the
expression of MPB-fusion proteins because it is ideal for Ptac expression vectors such as pMALc6t and is deficient in proteases Lon and OmpT. The transformed cells (100

L) were then

spread onto LB/Amp plates and grown overnight at 37 oC.

Expression and purification of Assembly 4 (6-His-MBP-TEV-DM64 (L1A) fusion protein)
Four transformed colonies of NEBExpress E. coli containing the 6-His-MBP-TEV-DM64
(L1A) constructs from Assembly 4 were screened for IPTG-induced protein production by
inoculating four separate 10 mL liquid LB/Amp media tubes containing 1 mM IPTG, incubated
at 37 oC with overnight shaking at 250 rpm, and protein production was assessed via SDS-PAGE
inspection. Once screened, the transformation colony showing the most IPTG-induced protein
production was subjected to large-scale expression of the N-terminal MBP-oprin protein. This
was accomplished by inoculating 1 L of liquid LB/Amp/Glu (containing 1mM glucose) media
with a 10 mL starter culture of NEBExpress E. coli cells containing the previously screened
Assembly 2 transformed colony. (Note: The addition of glucose is recommended as it inhibits
the production of amylase, an enzyme that can degrade the amylose resin used in subsequent
purification steps). Cells were initially incubated at 37 oC with shaking at 250 rpm until the
cultures reached 0.4 OD600, the temperature was then decreased to 30 oC, IPTG (final
concentration of 1 mM) was added and the cells were incubated at 30 oC for an additional six

hours. (Note: we found that if cultures were grown at 37 oC or for extended time periods,
significant inclusion body formation was observed, data not shown). The cells were then
harvested at 4,000 G at 4 oC, the supernatant was decanted, and the cell pellets were frozen at -20
o

C overnight. The cell pellets were re-suspended in a total of 60 mL of column buffer (20 mM

Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, and 0.5 mM DTT) containing 10 mg lysozyme
and 100

L HALT protease inhibitor (Sigma). (Note: The addition of lysozyme and the protease

inhibitor cocktail increased recovery of soluble MBP-oprin fusion protein significantly, data not
shown). The sample was incubated on ice for 10 minutes to induce cell lysis, sonicated with ten
30 sec bursts at 25 Hz on ice, and centrifuged at 15,000 x G for 20 min at 4 oC.

Affinity Purification with Ni-column
The combined supernatants were decanted and purified at 25 oC using 5 cm3 of HisPur
Ni-NTA resin (ThermoScientific) according to the manufacture’s protocol. The resin was
equilibrated with 30 mL lysis buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 10 mM imidazole),
the entire cell free lysate supernatant added to the resin and gently shaken at 4 oC for 1 hr. This
mixture was poured into a glass column and washed using 100 mL of wash buffer (25 mM TrisHCl pH 8, 400 mM NaCl, 25 mM imidazole) with a flow rate of 4.0 mL/min. The target protein
was eluted in 2.0 mL fractions using elution buffer (25 mM Tris-HCl pH 8, 400 mM NaCl, 0.5
M imidazole) with a flow rate of 4.0 mL/min. Eluted fractions were examined for quantity and
purity using the Bradford protein assay and SDS-PAGE, the fractions containing purified MBPTEV-DM64 (L1A) pooled.

Affinity Purification with Amylose-column
The pooled Ni-purified fractions were applied to 40 cm3 of amylose resin (NEB)
equilibrated in column buffer with 1M NaCl added (Note: the addition of NaCl to the column
buffer for equilibration and rinsing of the amylose column significantly reduced non-specific
binding, see supplemental). A flow rate of 4.0 mL/min was used to rinse the column with 100
mL of column buffer with 1M NaCl added, and the MBP-TEV-DM64 (L1A) fusion protein was
eluted into 3 mL fractions with column buffer containing 10 mM maltose but lacking the added
1M NaCl. Eluted fractions were examined for quantity and purity using the Bradford protein
assay and SDS-PAGE, the fractions containing the purified MBP-TEV-DM64 (L1A) fusion
protein were pooled and concentrated to a final concentration of 5.0 mg/ml (~67 nM, based on a
calculated molecular weight of 75,001 g/mol and a calculated extinction coefficient of 122,245
M-1cm-1) (values obtained from the ExPASy ProtParam tool).(Gasteiger et al., 2005)

(Assembly 5) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM43 expression vector
Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished using Q5
Hot Start High-Fidelity Polymerase 2X master mix with primers M and N (primer sequences
provided in supplemental). A 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix,
1.25µL of 10µM primer M, 1.25 µL of 10µM primer N, 1µL of pET His6-MBP-Asn10-TEV
template DNA (1 pg), and 9µL ultrapure H2O. Thermocycler reaction conditions for the pET28a
linearization reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 71 oC, 4 min 72
o

C (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the
oprin(DM43) coding sequence, the appropriate region of the synthetic pUC19-oprin(DM43)
plasmid (Genescript) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix
and primers P and O. A 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix, 1.25µL
of 10µM primer O, 1.25 µL of 10µM primer P, 1µL of synthetic pUC19-oprin(DM43) template
DNA (~2 pg), and 9µL ultrapure H2O. Thermocycler reaction conditions for the oprin
amplification reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 65 oC, 30 sec 72
o

C (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified

by 1.0% agarose gel (stained with EtBr) (see supplemental), bands were excised, DNA was
isolated using a Monarch DNA Gel Extraction Kit, and DNA concentration was determined
using a micro-volume spectrophotometer.

Lane (KEEP LANES 1,5,6)
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1)
½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1)
½ of PCR reaction
4 oprin insert (876 BP) – previously
synthesized
5 pET-6His-MBP-10Asn-TEVDM43 (insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEVDM43 (insert 5) ½ of PCR reaction

P

Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with
DpnI for 30 min at 37 oC in a reaction containing 8 µL (91ng) of linearized pET-His6-MBPAsn10-TEV, 1µL of 10X CutSmart buffer, and 1µL (20 units) of DpnI, followed by 20 min heat
inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol of the pET-His6MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the oprin(DM43)
amplification fragment (insert) (~1:2 vector) were combined in a 20

L assembly reaction with

10 µL of NEBuilder HiFi DNA 2X assembly master mix held at 50 oC for 30 minutes. NEB-5-a
competent cells (NEB) were transformed with 2µL of the assembly reaction following the
manufacture’s 42 oC heat-shock protocol, incubated in SOC media at 37 oC for 60 min, and
100µL was spread on LB/Kan agar plates and incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 5 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM43 specific primers A and B
(876 BP amplicon). Six colonies from the Gibson Assembly were randomly screened in separate
25 µL PCR reactions containing: 12.5 µL OneTaq, 1.25 µL of 10 µM primer A, 1.25 µL of 10
µM of primer B, and 10 µL ultrapure H2O, and individual colonies were picked with a sterile
micro-pipette tip as the DNA source (note: these same tips were used to inoculate separate 10
mL LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler
conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 56 oC, 60
sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized
by 1% agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7 and 8
respectively)

Lane
1- 1KB DNA ladder
2- Blank
3- Colony 5A
4- Colony 5B
5- Colony 5C
6- Colony 5D
7- Colony 5E
8- Colony 5F
9- Negative control
10-

Primer Control

DNA isolation and sequencing
Plasmid DNA from the three Assembly 5 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch Plasmid Miniprep
Kit (NEB), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these
purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San
Francisco, CA) using primers AA and CC. Reads were trimmed and aligned (data not shown)

using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

(Assembly 6) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM43 (L1A mutant)
expression vector
Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished
using Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers M and N (primer
sequences provided in supplemental). A 25 µL PCR reaction contained: 12.5 µL of Q5 2X
master mix, 1.25µL of 10µM primer M, 1.25 µL of 10µM primer N, 1µL of pET His6-MBPAsn10-TEV template DNA (1 pg), and 9µL ultrapure H2O. Thermocycler reaction conditions
for the pET28a linearization reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec
71 oC, 4 min 72 oC (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the
oprin(DM43) (L1A mutant) coding sequence, the appropriate region of the synthetic pUC19oprin(DM43) plasmid (Genescript) was amplified using Q5 Hot Start High-Fidelity Polymerase
2X master mix and primers Q and R. A 25 µL PCR reaction contained: 12.5 µL of Q5 2X
master mix, 1.25µL of 10µM primer Q, 1.25 µL of 10µM primer R, 1µL of synthetic pUC19oprin(DM43) template DNA (~2 pg), and 9µL ultrapure H2O. Thermocycler reaction conditions
for the oprin amplification reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 67
o

C, 30 sec 72 oC (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths

were verified by 1.0% agarose gel (stained with EtBr) (see supplemental), bands were excised,

DNA was isolated using a Monarch DNA Gel Extraction Kit, and DNA concentration was
determined using a micro-volume spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert 1) ½
of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert 1) ½
of PCR reaction
4 oprin insert (876 BP) – previously
synthesized
5 pET-6His-MBP-10Asn-TEV-DM43
(insert 5) ½ of PCR reaction
6 pET-6His-MBP-10Asn-TEV-DM43
(insert 5) ½ of PCR reaction

Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with DpnI
for 30 min at 37 oC in a reaction containing 8 µL (91ng) of linearized pET-His6-MBP-Asn10TEV, 1µL of 10X CutSmart buffer, and 1µL (20 units) of DpnI, followed by 20 min heat

inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol of the pET-His6MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the oprin(DM43) (L1A
mutant) amplification fragment (insert) (~1:2 vector) were combined in a 20L assembly reaction
with 10 µL of NEBuilder HiFi DNA 2X assembly master mix held at 50 oC for 30 minutes.
NEB5- a competent cells (NEB) were transformed with L of the assembly reaction following the
manufacture’s 42 oC heat-shock protocol, incubated in SOC media at 37 oC for 60 min, and
100µL was spread on LB/Kan agar plates and incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 6 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM43 specific primers A and B
(876 BP amplicon). Six colonies from the Gibson Assembly were randomly screened in separate
25 µL PCR reactions containing: 12.5L OneTaq, 1.25 µL of 10 µM primer A, 1.25 µL of 10 µM
of primer B, and 10 µL ultrapure H2O, and individual colonies were picked with a sterile micropipette tip as the DNA source (note: these same tips were used to inoculate separate 10 mL
LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler
conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 56 oC, 60
sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized
by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7 and 8
respectively)

Lane
1-

1KB DNA ladder

2-

Blank

3-

Colony 6A

4-

Colony 6B

5-

Colony 6C

6-

Colony 6D

7-

Colony 6E

8-

Colony 6F

9-

Blank

10- Negative control
11- Blank
12- Primer Control

DNA isolation and sequencing
Plasmid DNA from the three Assembly 6 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch Plasmid Miniprep
Kit (NEB), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these
purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San

Francisco, CA) using primers AA and CC. Reads were trimmed and aligned (data not shown)
using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

(Assembly 7) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM64 expression vector
Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished using Q5
Hot Start High-Fidelity Polymerase 2X master mix with primers M and N (primer sequences
provided in supplemental). A 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix,
1.25µL of 10µM primer M, 1.25 µL of 1µM primer N, 1µL of pET His6-MBP-Asn10-TEV
template DNA (1 pg), and 9µL ultrapure H2O. Thermocycler reaction conditions for the pET28a
linearization reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 71 oC, 4 min 72
o

C (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the DM64
coding sequence, the appropriate region of the synthetic pUC19-DM64 plasmid (BioTwist) was
amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix and primers S and T. A
25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix, 1.25µL of 10µM primer S, 1.25
µL of 10µM primer T, 1µL of synthetic pUC19-DM64 template DNA (~2 pg), and 9µL
ultrapure H2O. Thermocycler reaction conditions for the oprin amplification reaction were:
Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 66 oC, 60 sec 72 oC (35 cycles); Stage 3: 10
min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified by 1.0% agarose gel (stained
with EtBr) (see supplemental), bands were excised, DNA was isolated using a Monarch DNA

Gel Extraction Kit, and DNA concentration was determined using a micro-volume
spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert
1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert
1) ½ of PCR reaction
4 oprin insert (876 BP) –
previously synthesized
5 pET-6His-MBP-10Asn-TEVDM43 (insert 5) ½ of PCR
reaction
6 pET-6His-MBP-10Asn-TEVDM43 (insert 5) ½ of PCR
reaction

Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with DpnI
for 30 min at 37 oC in a reaction containing 8 µL (91ng) of linearized pET-His6-MBP-Asn10-

TEV, 1µL of 10X CutSmart buffer, and 1µL (20 units) of DpnI, followed by 20 min heat
inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol of the pET-His6MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the DM64 amplification
fragment (insert) (~1:2 vector) were combined in a 20 µL assembly reaction with 10 µL of
NEBuilder HiFi DNA 2X assembly master mix held at 50 oC for 30 minutes. NEB5-a
competent cells (NEB) were transformed with 2µL of the assembly reaction following the
manufacture’s 42 oC heat-shock protocol, incubated in SOC media at 37 oC for 60 min, and
100µL was spread on LB/Kan agar plates and incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 7 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W and X
(1440 BP amplicon). Six colonies from the Gibson Assembly were randomly screened in
separate 25 µL PCR reactions containing: 12.5 µL OneTaq, 1.25 µL of 10 µM primer W, 1.25
µL of 10 µM of primer X, and 10 µL ultrapure H2O, and individual colonies were picked with a
sterile micro-pipette tip as the DNA source (note: these same tips were used to inoculate separate
10 mL LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler
conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60
sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized
by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction
with no DNA and a negative primer control with only one primer were also run – Lanes 7 and 8
respectively)

Lane
1- 1KB DNA ladder
2- Colony 7A
3- Colony 7B
4- Colony 7C
5- Colony 7D
6- Colony 7E
7- Colony 7F
8- Negative control
9- Primer Control

NOTE: Re-did gel because it looks like only 5 colonies but there should be 6. Same results, no
mistake, therefore Colony #6 did not amplify.

DNA isolation and sequencing
Plasmid DNA from the three Assembly 7 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch Plasmid Miniprep
Kit (NEB), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these

purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San
Francisco, CA) using primers AA and CC. Reads were trimmed and aligned (data not shown)
using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

(Assembly 8) Gibson Assembly of pET-His6-MBP-Asn10-TEV-DM64 (L1A mutant) expression
vector
Linearization of the pET-His6-MBP-Asn10-TEV vector (Addgene) was accomplished
using Q5 Hot Start High-Fidelity Polymerase 2X master mix with primers M and N (primer
sequences provided in supplemental). A 25 µL PCR reaction contained: 12.5 µL of Q5 2X
master mix, 1.25µL of 10µM primer M, 1.25 µL of 10µM primer N, 1µL of pET His6-MBPAsn10-TEV template DNA (1 pg), and 9µL ultrapure H2O. Thermocycler reaction conditions
for the pET28a linearization reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec
71 oC, 4 min 72 oC (35 cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC.

To introduce overlapping pET-His6-MBP-Asn10-TEV regions on both ends of the DM64
(L1A mutant) coding sequence, the appropriate region of the synthetic pUC19-DM64 plasmid
(BioTwist) was amplified using Q5 Hot Start High-Fidelity Polymerase 2X master mix and
primers U and V. A 25 µL PCR reaction contained: 12.5 µL of Q5 2X master mix, 1.25µL of
10µM primer U, 1.25 µL of 10µM primer V, 1µL of synthetic pUC19-DM64 template DNA (~2
pg), and 9µL ultrapure H2O. Thermocycler reaction conditions for the oprin amplification
reaction were: Stage 1: 60 sec 98 oC; Stage 2: 30 sec 98 oC, 30 sec 67 oC, 60 sec 72 oC (35
cycles); Stage 3: 10 min 72 oC; Stage 4: 4 oC. Assembly fragment lengths were verified by 1.0%

agarose gel (stained with EtBr) (see supplemental), bands were excised, DNA was isolated using
a Monarch DNA Gel Extraction Kit, and DNA concentration was determined using a microvolume spectrophotometer.

Lane
1 MW ladder
2 pMAL-c6t-TEV-DM43 (insert
1) ½ of PCR reaction
3 pMAL-c6t-TEV-DM43 (insert
1) ½ of PCR reaction
4 oprin insert (876 BP) –
previously synthesized
5 pET-6His-MBP-10Asn-TEVDM43 (insert 5) ½ of PCR
reaction
6 pET-6His-MBP-10Asn-TEVDM43 (insert 5) ½ of PCR
reaction

Prior to Gibson Assembly, linearized pET-His6-MBP-Asn10-TEV was treated with DpnI
for 30 min at 37 oC in a reaction containing 8 µL (91ng) of linearized pET-His6-MBP-Asn10-

TEV, 1µL of 10X CutSmart buffer, and 1µL (20 units) of DpnI, followed by 20 min heat
inactivation at 80 oC. Gibson Assembly conditions were as follows: 0.01 pmol of the pET-His6MBP-Asn10-TEV linearized fragment (vector) and 0.035 pmol of the DM64 (L1A mutant)
amplification fragment (insert) (~1:2 vector) were combined in a 20 µL assembly reaction with
10 µL of NEBuilder HiFi DNA 2X assembly master mix held at 50 oC for 30 minutes. NEB5-a
competent cells (NEB) were transformed with 2µL of the assembly reaction following the
manufacture’s 42 oC heat-shock protocol, incubated in SOC media at 37 oC for 60 min, and
100µL was spread on LB/Kan agar plates and incubated at 37 oC overnight.

Colony PCR of Gibson Assembly transformation colonies
Colonies from Assembly 8 were screened by colony PCR in separate reactions using
OneTaq Quick-Load 2X Master Mix with standard buffer and DM64 specific primers W and X
(1440 BP amplicon). Six colonies from the Gibson Assembly were randomly screened in
separate 25 µL PCR reactions containing: 12.5 µL OneTaq, 1.25 µL of 10 µM primer W, 1.25
µL of 10 µM of primer X, and 10 µL ultrapure H2O, and individual colonies were picked with a
sterile micro-pipette tip as the DNA source (note: these same tips were used to inoculate separate
10 mL LB/Amp cultures grown overnight at 37 oC with shaking at 250 rpm. PCR thermocycler
conditions for colony PCR were: Stage 1: 2 min 94 oC; Stage 2: 30 sec 94 oC, 30 sec 60 oC, 60
sec 68 oC (35 cycles); Stage 3: 10 min 68 oC; Stage 4: 4 oC. Colony PCR results were visualized
by 1.0% agarose gel (stained with EtBr) (see supplemental). (Note: a negative control reaction

with no DNA and a negative primer control with only one primer were also run – Lanes 7 and 8
respectively)

Lane
1-

1KB DNA ladder

2-

Colony 8A

3-

Colony 8B

4-

Colony 8C

5-

Colony 8D

6-

Colony 8E

7-

Colony 8F

8-

Negative control

9-

Primer Control

DNA isolation and sequencing
Plasmid DNA from the three Assembly 8 transformation colonies was isolated from 1.5
mL of the LB/Amp liquid cultures of colonies showing appropriate amplicon length from colony
PCR as visualized by 1.0% agarose gel (stained with EtBr) using the Monarch Plasmid Miniprep
Kit (NEB), eluted with 20 mL of elution buffer to give final plasmid DNA concentrations
between 20-120 ng/ mL as measured using a micro-volume spectrophotometer. Three of these
purified plasmids were submitted for Sanger dideoxy-sequencing (MCLAB, South San

Francisco, CA) using primers AA and CC. Reads were trimmed and aligned (data not shown)
using freeware FinchTV and UniProUGENE software (see supplemental for plasmid map and
complete DNA and putative protein sequences).(FinchTV; Okonechnikov et al., 2012)

Expression and purification of C-term 6-His-oprin protein
Four transformed colonies of BL23(DE) E. coli containing the 6-His tag pMAL-oprin
constructs from each assembly were screened for IPTG-induced protein production by
inoculating four separate 10 mL liquid LB/Kan media tubes containing 1 mM IPTG, incubated at
37 oC with overnight shaking at 250 rpm. Two separate 2 L media flasks each containing 1 L of
liquid LB/Amp media were inoculated with 10 mL of the starter culture. Cells were incubated at
37 oC with shaking at 250 rpm until the culture reached 0.5 OD600, IPTG (final concentration of
1 mM) was added and the cells were incubated at 30 oC for an additional 6 h (Note: 30 oC
incubation was found to give the most soluble protein, data not shown). The cells were harvested
by centrifugation at 4,000 G for 20 min at 4 oC, the supernatant was decanted, and the cell pellet
was frozen at -20 oC overnight. The pellet was re-suspended in 25 mL lysis buffer (20 mM TrisHCl pH 8, 200 mM NaCl, 1 mM EDTA, 0.5 mM DTT) containing 10 mg lysozyme and 100

L

HALT protease inhibitor (Sigma). (Note: The addition of lysozyme and the protease inhibitor
cocktail increased recovery of soluble MBP-oprin fusion protein significantly, data not shown).
The supernatant was decanted and applied to 40 cm3 of amylose resin (NEB) equilibrated in
column buffer with 1M NaCl added (Note: the addition of NaCl to the column buffer for
equilibration and rinsing of the amylose column significantly reduced non-specific binding, see
supplemental). A flow rate of 4.0 mL/min was used to rinse the column with 100 mL of column
buffer with 1M NaCl added, and the MBP-TEV-DM43 or MBP-TEV-DM64 fusion protein was

eluted into 3 mL fractions with column buffer containing 10 mM maltose but lacking the added
1M NaCl. Eluted fractions were examined for quantity and purity using the Bradford protein
assay and SDS-PAGE, the fractions containing the purified fusion protein were pooled and
concentrated ( based on a calculated molecular weight of 75,001 g/mol and a calculated
extinction coefficient of 122,245 M-1cm-1) (values obtained from the ExPASy ProtParam
tool).(Gasteiger et al., 2005). This buffer exchange was required to eliminate residual imidazole
that can interfere with downstream inhibitor assays. A flow rate of 5. mL/ min was used, and 1
mL of the concentrated protein was then applied to a Sephacryl 200 200mL size exclusion
column. 60 fractions were collected over night and then the eluted fractions were examined for
quantity and purity using the Bradford protein assay and SDS-PAGE. the fractions containing the
purified MBP-oprin fusion protein were pooled and exchanged into TNCT buffer (50 mM Tris–
HCl pH 7.5, 150 mM NaCl, 1 mM CaCl2, and 0.02% Tween-20) utilizing a 10,000 MWCO
centrifugal concentrator (EMDMillipore) to a final concentration of 5.0 mg/ml (~67 nM, based
on a calculated molecular weight of 75,001 g/mol and a calculated extinction coefficient of
122,245 M-1cm-1) (values obtained from the ExPASy ProtParam tool).(Gasteiger et al., 2005)
This buffer exchange was required in our hands to eliminate residual EDTA and DTT,
components that can interfere with downstream steps such as proteolytic cleavage or inhibitor
assays.(Jenny et al., 2003; Waugh, 2011).

Cleavage of MBP-Oprin with TEV protease of Assembly 2 fusion protein

Partial proteolytic cleavage of the MBP fragment was achieved by allowing 50 µL of
TEV protease to react with 500µL of the purified MBP-oprin fusion protein purified from the
Sephacryl 200 column for 24 hours at 4 oC (Note: a variety of conditions were examined to
optimize cleavage, data not shown). The resulting cleavage reaction was analyzed by SDSPAGE. The remaining reaction solution was combined with HiPur Ni-NTA Resin equilibrated in
the lysis buffer (20 mM Tris-HCl pH 8, 200 mM NaCl, 1 mM EDTA, 0.5 mM DTT). The
reaction mixture was left to rock at 4 oC overnight. The supernatant was collected, and the results
were examined by SDS-PAGE.
Lanes
1- 10 µL Molecular
weight standard ladder
2- Fraction 6 Assembly 1
no TEV
3- Werner Supernatant
4-Cook Supernatant
5- Smith Supernatant
6-Werner TEV
7-Cook TEV
8- Smith TEV

Continuous Fluorescent Peptide Hydrolysis Inhibition Assay
The fluorescent peptide substrate (Abz-AGLA-Nbz), has been utilized as an effective
substrate to determine kinetic parameters of a variety of proteases as well as SVMPs and their
associated inhibitors. (Nishino and Powers, 1980; Rush et al., 1984; Neves-Ferreira et al., 2000;
Jurgilas et al., 2003; Villalta-Romero et al., 2012) A portion of an 8 mM Abz-AGLA-Nbz
dissolved in a H2O:DMSO (9:1) stock solution was diluted 200-fold (0.04 mM final
concentration) in TNCT buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM CaCl2, and
0.02% Tween-20) in a 40 mL plastic trough. A series of six 3-fold dilutions of TNCT buffer
were created using serial dilution technique. In 9 microcentrifuge tubes, 100µL of 5000X
dilution of C. Atrox venom was added. In the 10th control tube, 200µL of TNCT buffer was
added as a negative control group. 100 µL of each of the inhibitor dilutions were added to its
respective tube and mixed by inversion. In the seventh tube 100 µL of the concentrated inhibitor
stock was added. 100 µL of 100mM EDTA was added to the 8th tube as an EDTA control. 100
µL of the TNCT buffer was added to the 9th tube, which acted as the positive control. The 10
tubes were pre-incubated for 2 h at room temperature. Black 96-well plates were used to
perform triplicate measurements. Next 100 µL of the diluted substrate in TNCT was added into
wells A1- C10 using a 300 µL 8 channel pipettor. 170 µL of the 10 pre-incubated tubes was
added to wells H1-H10. 50µL from wells H1-8 were added to A1-A8. This process was repeated
for rows B and C as well. The plate was then read at 37 oC using excitation and emission
wavelengths of 340nm and 415nm, respectively, for 10 minutes at 30 sec intervals.

Results and Discussion

Production via bacterial vectors of recombinant SVMPIs
The production of soluble mammalian proteins using recombinant expression vectors in
bacteria can be both challenging and rewarding. Mammalian proteins typically contain posttranslational modifications (i.e. glycosylation, signal sequence cleavage) that are not found in
bacterial systems.(Altenbuchner and Mattes, 2006) These issues can often lead to the production
of proteins in bacteria that are neither soluble nor active, and can limit the use of this
approach.(Hochkoeppler, 2013) However, the production of mammalian proteins in bacteria,
most notably E. coli, for structural and functional studies has a rich history and remarkable
success rate.(Sahdev et al., 2008) The use of affinity tags as well as solubilization fusion
proteins has increased the successful production of mammalian proteins in bacteria
significantly.(Yang et al., 2016)
In response to the call for additional methods to understand the interaction of mammalian
SVMPIs and their target SVMPs,(Bastos et al., 2016) we expressed a SVMPI protein derived
from the N. American opossum (D. virginiana), originally termed “oprin” and subsequently
shown to be highly homologous to DM43, (Neves-Ferreira et al., 2002) utilizing two approaches
involving an affinity fusion tag. First, we investigated the production of a C-terminal 6-His
tagged oprin protein using pMAL and pET-series vectors. A cDNA derived sequence that
encodes for the oprin protein (GenBank AY131001.1) was chemically synthesized and produced
in a pUC19 vector. Appropriate overlapping ends were added to the coding sequence using PCR

and then inserted into the above linearized expression vectors with corresponding overlapping
ends using the Gibson Assembly procedure (Gibson et al., 2009).
The expression of C-terminal 6-His-oprin was accomplished by transforming NEB 5- a
Express E. coli cells with both the pMAL and pET oprin constructs. Upon the addition of IPTG
to large cultures entering the exponential growth phase, the 6-His-oprin protein (~33 kDa) was
produced. The cell lysate collected from the cells grown were purified 5 cm3 of HisPur Ni-NTA
resin (ThermoScientific) according to the manufacture’s protocol. The MBP-DM43 fusion
protein could be visualized via SDS-PAGE. Unfortunately, many other proteins were also
visualized after the HisPur Ni-NTA resin treatment. Fractions of the protein solution were
collected, and a notable protein concentration was found.
Two 2L flasks with 1000mL cultures of assemblies 1-4 were grown to increase the
amount of the MBP-DM43 fusion protein collected. The cell lysate from these cultures were first
applied to 40 cm3 of amylose resin (NEB) in order to purify the solution. The MBP-DM43 fusion
protein was visualized in both the “wash” and in fractions 1-20 vis SDS-PAGE analysis.
The “wash” collected from Assembly 1 was applied to the amylose column again and a
more purified product including the MBP-DM43 fusion protein was found via SDS-PAGE . A
fraction of this newly purified product was selected for TEV protease cleavage analysis. 500 µL
of the purified product was combined with purified TEV protease (100:1) from the labs of Dr.
Smith, Dr. Cook, and Dr. Werner and left for 24 hours at 4 oC. After the allotted time period,
partial cleavage of the fusion protein was observed.
The same TEV protease cleavage of Assembly 2 was performed. The reactions were left
for 24 hours at 4 oC and a sample was taken for analysis. Another sample was taken after 72

hours at the same temperature condition. Partial cleavage of the fusion protein could be seen via
SDS-PAGE analysis.
After Assembly 3 was purified applied to the amylose column, the fractions that were
found to contain protein via a Bradford assay analysis were combined and concentrated. The
concentrated solution was applied to a Sephacryl size exclusion column for further purification.
60 fractions were collected overnight, and a more purified product was found via SDS-PAGE
analysis. The same process was then applied to Assemblies 1,2, and 4.
Assembly 1 used in another TEV protease cleavage reaction using a Nickle TEV
protease cleavage reaction with the batch procedure. A TEV protease and MBP-DM43 fusion
protein solution (100:1) was applied to a solution of equilibrated Nickle resin following a batch
procedure. Further cleavage and purification were observed via SDS-PAGE analysis.

Primers Used (ordered from IDT 5/1/2021)

Name

Sequence

A oprin-DM43_fwd

ttaaaggctatggacccaactcctc

B oprin-DM43_rev

tcactggcctgtagtgacgaccagc

C pMAL-c6T_fwd

ccgaattccctgcaggtaattaaataag

D pMAL-c6T_rev

ctggaagtacaggttctccc

E oprin-DM43_fwd

caacctcggggagaacctgtacttccagttaaaggctatggacccaactc

F oprin-DM43_rev

cttatttaattacctgcagggaattcggtcactggcctgtagtgacgac

G L1A oprin-DM43_fwd

caacctcggggagaacctgtacttccaggcaaaggctatggacccaac

H L1A oprin-DM43_rev

cttatttaattacctgcagggaattcggtcactggcctgtagtgacgac

I DM64_fwd

caacctcggggagaacctgtacttccagttggctatggaaacaactcctc

J DM64_rev

cttatttaattacctgcagggaattcggtcactggcctgtcacctgaag

K L1A DM64_fwd

caacctcggggagaacctgtacttccaggcggctatggaaacaactcc

L L1A DM64_rev

cttatttaattacctgcagggaattcggtcactggcctgtcacctgaag

M pET TEV_fwd

ccgtcgacaagcttgcggcc

N pET TEV_rev

ttggaagtacaggttttcctcgatccc

O oprin-DM43_fwd

cgggatcgaggaaaacctgtacttccaattaaaggctatggacccaactc

P oprin-DM43_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtagtgacgac

Q L1A oprin-DM43_fwd

cgggatcgaggaaaacctgtacttccaagcaaaggctatggacccaac

R L1A oprin-DM43_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtagtgacgac

S DM64_fwd

cgggatcgaggaaaacctgtacttccaattggctatggaaacaactcctc

T DM64_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtcacctgaag

U L1A DM64_fwd

cgggatcgaggaaaacctgtacttccaagcggctatggaaacaactcc

V L1A DM64_rev

tcgagtgcggccgcaagcttgtcgacggtcactggcctgtcacctgaag

W DM64_fwd

ttggctatggaaacaactcctcgcc

X DM64_rev

tcactggcctgtcacctgaagctct

AA FWD_Seq

GGTCGTCAGACTGTCGATGAAGCC

BB REV_Seq

TGTCCTACTCAGGAGAGCGTTCAC

CC Rev_T7 Seq

GCTAGTTATTGCTCAGCGG
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Artist’s Statement
This series of work was created to act as an educational guide to illustrate the history and
methods of the Werner Lab processes regarding the bacterial production of metalloproteinase
inhibitors. The first piece in the series depicts Dr. Werner Sr. working in a military lab,
conducting the foundational research to the physiological effects of the venom of eastern
diamondback rattle snakes on the North American Opossum. The second piece in the series is a
break-down of the pathway that snake venom follows during a human snake bite envenomation.
The effects of the two major components in the snake’s venom can be seen. The third piece in
the series is a depiction of the lab processes used to create the DNA of the bacterial vector used

that contained the genes for the proteins of interest. The final piece in the series outlines the
processes used to further purify the MBP-DM43 fusion protein

Works
FIGURE A.
A depiction of Dr. Robert M. Werner, DVM conducting the foundational snake venom research
at Edgewood Arsenal Biomedical Laboratory

FIGURE B. Illustration of the process of envenomation. The structures effected by the venom
and enzymes responsible are highlighted

FIGURE C. A depiction of the
methods used in the lab to create the
new oprin gene containing vector
through the usage of a Gibson
Assembly and bacterial
transformation

FIGURE D. outline of the steps used to purify the MBP-DM43 fusion protein as mentioned
above

Process
A multistep collaborative process between Dr. Werner and the artist was used to create
the series. The process began with the decision of what laboratory processes should be
highlighted to give viewer a complete picture of everything done in lab. A series of pre-existing
scientific diagrams along with real world references were used to start the process. From there
the artist created multiple renditions of the proposed composition (fig E.). These renditions were
done with simple mock-up using pen and alcohol based illustrator’s markers. Dr. Werner and the
artist then discussed the composition and elements further. Once a composition was agreed upon,
the final drawing was completed using an Apple iPad, Apple Pencil, and the application
Procreate. The final part of the process was done by collaging the individual works together
using Adobe Photoshop.

Preliminary Work

FIG E The original photo of Dr. Werner DVM preforming tests on a sedated opossum. The final
illustration was changed so show Dr. Werner holding an Eastern Diamondback Rattlesnake
instead of the IV shown in the reference.

FIG F In the digital illustration phase, an outline was made and perfected. A black and gray layer
is created next and the color is added to a separate final layer.

FIG G various compositions were experimented with in order to properly display all the
information.

FIG H Eastern Diamondback Rattlesnake study
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